Laobaixing Pharmacy
LBX Pharmacy Chain Joint Stock Company operates a chain of pharmacy stores in Mainland China. The company operates through three segments: Retail business, Wholesale business, and Other. It engages in commodity retail and wholesale business; and pharmaceutical manufacturing business and others, as well as sells drugs, and other health and beauty-related products through its marketing network. The… Read more
Laobaixing Pharmacy (603883) - Total Assets
Latest total assets as of September 2025: CN¥20.34 Billion CNY
Based on the latest financial reports, Laobaixing Pharmacy (603883) holds total assets worth CN¥20.34 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Laobaixing Pharmacy - Total Assets Trend (2011–2024)
This chart illustrates how Laobaixing Pharmacy’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Laobaixing Pharmacy - Asset Composition Analysis
Current Asset Composition (December 2024)
Laobaixing Pharmacy's total assets of CN¥20.34 Billion consist of 41.0% current assets and 59.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 10.7% |
| Accounts Receivable | CN¥2.95 Billion | 13.3% |
| Inventory | CN¥3.57 Billion | 16.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥845.35 Million | 3.8% |
| Goodwill | CN¥5.76 Billion | 26.0% |
Asset Composition Trend (2011–2024)
This chart illustrates how Laobaixing Pharmacy's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Laobaixing Pharmacy's current assets represent 41.0% of total assets in 2024, a decrease from 73.6% in 2011.
- Cash Position: Cash and equivalents constituted 10.7% of total assets in 2024, down from 24.5% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 28.0% of total assets, an increase from 8.0% in 2011.
- Asset Diversification: The largest asset category is goodwill at 26.0% of total assets.
Laobaixing Pharmacy Competitors by Total Assets
Key competitors of Laobaixing Pharmacy based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
Laobaixing Pharmacy - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Laobaixing Pharmacy generates 1.01x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Laobaixing Pharmacy generates $ 2.34 in net profit.
Laobaixing Pharmacy - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.87 | 0.85 | 0.90 |
| Quick Ratio | 0.50 | 0.48 | 0.52 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-1.27 Billion | CN¥ -1.54 Billion | CN¥ -656.61 Million |
Laobaixing Pharmacy - Advanced Valuation Insights
This section examines the relationship between Laobaixing Pharmacy's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.66 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 4.4% |
| Total Assets | CN¥22.16 Billion |
| Market Capitalization | $739.96 Million USD |
Valuation Analysis
Below Book Valuation: The market values Laobaixing Pharmacy's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Laobaixing Pharmacy's assets grew by 4.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Laobaixing Pharmacy (2011–2024)
The table below shows the annual total assets of Laobaixing Pharmacy from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥22.16 Billion | +4.36% |
| 2023-12-31 | CN¥21.23 Billion | -0.78% |
| 2022-12-31 | CN¥21.40 Billion | +26.18% |
| 2021-12-31 | CN¥16.96 Billion | +50.28% |
| 2020-12-31 | CN¥11.28 Billion | +13.70% |
| 2019-12-31 | CN¥9.92 Billion | +16.97% |
| 2018-12-31 | CN¥8.48 Billion | +26.66% |
| 2017-12-31 | CN¥6.70 Billion | +36.44% |
| 2016-12-31 | CN¥4.91 Billion | +29.18% |
| 2015-12-31 | CN¥3.80 Billion | +50.24% |
| 2014-12-31 | CN¥2.53 Billion | +16.06% |
| 2013-12-31 | CN¥2.18 Billion | +34.94% |
| 2012-12-31 | CN¥1.62 Billion | +6.25% |
| 2011-12-31 | CN¥1.52 Billion | -- |